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Summary 
Complement was shown to enhance 
the n~utralization of herpes simplex virus. 
Early and late rabbit anti-herpes sera 
neutralized virus in the absence of com-
plement, although neutralization was 
enhanced on the addition of complement. 
In the lit~rature, these types of antibodies 
have been classed as non-complement 
requiring neutralising antibodies (non-
CRN antibodies). 
Preliminary investigation with early 
(acute) human anti-herpes serum showed 
low or negligible neutralization in the 
absence of complement which was greatly 
enhanced when complement was added. 
The late (convalescent) human anti-herpes 
serum neutralized virus in the absence of 
complement although again, enhancement 
occurred when complement was present. 
Complement-requiring neutralizing anti-
bodies (eRN antibodies) were thus the 
main types of antibodies present in the 
early phases after infection with herpes 
virus and thes~ were later replaced, as the 
infection progressed, by non-CRN anti-
bodies. 
Attempts were made to demonstrate 
the types and time of appearance of CRN 
and non-CRN antibodi,es in mice after im-
munization with herpes virus. Early 
mouse anti-herpes serum showed low 
neutralizing activity in the absence of 
complement which was only slightly 
enhanced by the addition of complement. 
Later sera appeared to contain antibodies 
of the non-CRN type since neutralization 
was marked in the absence of complement. 
Introduction 
It has been known for some time that 
a factor present in normal' serum enhances 
the action of neu'traliz,ing antibodies aga-inst 
various types of viwses. Gordon (1925) 
working with vaccinia virus showed that 
heating lowered the neutralizing potency 
of immune serum. The enhandng effect of 
a heat-labile substance on the neutralizing 
activity of immune serum was demons-
tr~ated for Rous sarcoma virUlS (Muller, 
1931), Western equine encephalitis virus 
(Morgan, 1945; Whitman, 1947), mumps 
virus (Leymaster and Ward, 1949), New-
castle disease virus (Howitt, 1950), dengue 
fever virus (Sabin, 1950) and variola virus 
(McCarty and Germer, 1952). Dozois et al. 
(1949) showed that the nature of the heat-
labile substance responsible for the en-
hancing effect on anti-WEE neutralizing 
antibodies were the second, third and 
fOlurth components of complement. The 
role of complement as the enhancing factor 
in virus neutralization was firmly estab-
lished by sim'ilar studies with herpes 
simplex virus (Taniguchi and Yoshino, 
1965). 
Early and late ,immune sera differ in 
their requirement for complement for sub-
sequent neutralization of virus. Thus, 
studies with early sera obtained from rab-
bits immun'ized with herpes simplex virus 
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showed that these mainly contained CRN 
antibodies while late sera were non-
complement requiring, although comple-
ment also enhanced the neutralizing acti-
vity of such late antisera (Yoshino and 
Taniguchi, 1964; WaHis and Melnick, 1971). 
SimHar results were obtained w'ith guinea 
pig anti-herpes sera {Yoshino and Tani-
guchi, 1966). Adler et al. '(1971) showed 
that complement amplifies the activity of 
rabbit anti coliphage early ,IgM and IgG 
antibodies up to a thousandfoid. 
CRN antibodies were also found in 
the early sera of rabbits arfificially in-
fected with herpes virus and in naturally 
infected man (Y oshino and Taniguchi, 
1964; 1966). In cases of herpes virus in-
fections, serum taken early in the disease 
was shown to neutralize virus only in the 
presence of complement. This finding has 
cons'iderable diagnostic value as the 
presence of CRN antibodies can be taken 
as evidence of inifection. The finding of 
CRN antibodies in early immune sera thus 
appears to be a common phenomenon 
since they have been detected in various 
species of either ,immunized or ,infected 
animals including man. 
This thesis examines the role of com-
plement in the neutral'ization of herpes 
simplex virus by early and late antisera 
ra'ised in rabbits by an immunization 
scheme ,which differs !from that employed 
by several authors (Yoshino and Tanigu-
chi, 1964; Hampar et al., 1968; WaUis and 
Melniok, 1971). The resulting differences 
obtained, especially with the early sera, 
will' be analysed and discussed. The 
results oiblta,ined with tihe human acute and 
convalescent anti-herpes sera were similar 
to those o.btained by Yoshino and Tanigu-
chi (1966). 
In order to investigate further the 
fime of appearance of eRN and non-CRN 
antibodies, mice were immunized with 
herpes simplex virus and the ,immune sera 
obtained at various time intervals were 
tested in neutralization experiments in the 
presence and absence of complement. The 
results were in many respects sim'ilar to 
those obtained by Yoshino and Taniguchi 
(1964) who used rabbits in their experi-
ments. 
Materials and Methods 
Cultured cells 
BHK21 0baby hamster kidney) cells 
(Macpherson and Stoker, 1961) were used 
throughout this study. 
Growth medium and diluents 
Cells were serially subcultured and 
maintained in modified Eagle's medium 
(Vantsis and W.Hdy, 1962) conta'ining 10% 
calf ser:um and 10% tryptose phosphate 
broth (ETC). Stock virus suspensions 
were prepared in ETC and, when diluted, 
the same medium was used as diluent. 
An sera and 'complement, whether un-
heated or inactivated, were diluted in 
Dulbecco A solution (0.8% NaCl, 0.02% 
KCl in phosphate buffer, pH 7.0) (Dulbec-
co and Vogt, 1954). 
Virus production 
The HFEM stra:in was used throu.gh-
out as herpes simplex virus tY'pe 1. This 
strain was also used to imm:un:ize rabbits 
and mice. Herpes simplex virus type 2 
(strain 3345) was. used in some of the 
neutralization tests, Both virus types 
were grown in BHK21 cells. The ceNs 
were first al'lowed to form confluent mono-
layers in 80 oz. Winchester bottles after 
which each was infected with 10' plaque 
forming units (p.f.u.) of virus in 20 ml 
ETC. The v'irus was allowed to adsorb 
for 60 min at 32 ° C and then a further 180 
ml of ETC was added and incu1bation con-
tinued for 2 to 3 days. Widespread 
cytopathic effect was usually observed by 
this time. After decanting most of ,the 
medium, the ce}.]:s were scraped off into 
a small volume of remaining ETC and 
then centrIfuged at 1000 rev jmin for 10 
min. The sedimerrted cells were resus-
pended in 5 ml fresh ETC and disrupted 
with an ultrason'ic probe (MSE Ltd., Craw-
ley, Sussex). The disrupted material was 
then centri1fuged at 4000 rev jmin for 15 
min, the supernatant fluid collected and 
stored in small volumes at -70°C until 
used. 
Virus assays 
Assays were performed by the suspen-
sion-plaque method of Russell (1962). 
Briefly, 2 ml of appropriate virus dilutions 
were incubated rw:ith 7 x 106 BHK cells 
for 60 min at 37°C on a shaker. Then, 8 
ml of 0.8% carboxymetlhyl cellu-
lose (CMC) in ETC (OMC/ETC), pre-
warmed to 37° C, were added and the 
resulting suspens'ion poured into two 45 
mm plast'c plates which were subse-
quently incubated at 37°C in a 5% CO z-
air incubator. At the end of the incuba-
tion period (usual'ly 2 days), the medium 
was decanted and the mono layers washed 
once with phosphate buffered saline. They 
were then fixed for 10 min with 10% 
formol saline. After remov.al of the fixa-
tive' the plates were washed in tap water 
and then stained with dilute carbol fuchsin 
for 10 min followed by washing twi'ce in 
tap water. Plaques were counted with a 
plate microscope using a x 2.5 magnifica-
tion. 
Neutralization tests 
Kinetic neutralization experiments 
were carried out throughout this study. 
Unless otherwise stated, the following 
vo.lumes of reagents and v'irus titres were 
used in these tests. 
0.05 ml of an appropriate dilution of 
immune serum was mixed with an equal 
volume of guinea pig complement diluted 
to contain 10 units in 0.05 ml volume. 
0.1 ml of a suspension of virus containing 
5 x 10-l p.f.u./ml was then added and the 
mixture left to 'incubate at room tempera-
ture for the time 'indicated in the Figures. 
Then 0.1 ml was diluted in 9.9 ml ETC 
and residual infectivity was assayed as 
described under virus assays. Parallel 
control samples were incubated with pre-
immunization serum in corresponding 
dilutions. The virus-serum mixtures tested 
'in the absence of complement contained 
inadivated guinea pi:g serum (Le., heated 
at 56°C for 30 min) in corresponding dilu-
tions and volumes and these were also 
tested 'in parallel with the samples con-
taining active (unheated) complement. 
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All sera were heated at 56°C for 30 
min before use. 
The neutralization rate constant, k, 
was then calculated from 
2.303 vo 
k = --log-
et v 
where c is the final concentration of anfi-
serum, t is the time :in min of neutraliza-
tion, Vo is the initial virus titre and v the 
res.idual virus infectivity. 
In some Figures, the loglo of the sur-
viving virus fraction is shown plotted 
against time; in other cases, the residual 
percentage infectivity (% surviving v,irus) 
is shown i.e., the residual infectiv'ity of 
the virus-antiserum mi~ture was expressed 
as a percentage of the infectivity of a 
mixture with pre-immunization serum at 
a corresponding dilution and after incuba-
tion for the same period. 
Anti-herpesvirus sera 
a) Rabbit immune sera 
These were produced as described by 
Watson et al. (1966). Briefly, virus was 
gmwn'in RK13 (mbbit kidney) cells which 
were then harvested, disrupted with an 
ultrasonic probe and the suspension finally 
freeze-dried. The immunizing antigen 
consisted oif 0.2 g of freeze-dried material 
(equiva,lent to approximately 6 x 109 
pJ.u.) mixed with 1.5 ml of incomplete 
Freund's adjuvant, the whole made up to 
5 ml with sterile water. The resulting 
emulsion was homogenized and injected 
intramuscularly. To beg.in with, seven 
fortnightly injections were given, the first 
containing ,formalinized antigen. Bleed-
ings were made 10 days after each injec-
tion and sera separated after standing ,the 
blood samples overnight at 4°C. (Sera are 
given laboratory identtfi'cation numbers; 
thus serum 466/1 is the sample taken 10 
days after the first .irrjection, 466 repre-
senting the rabbit number. Serum 466jHI 
is the sample taken from the same rabbit 
10 days after the third 'injection and so 
on). After the seventh injection, the rab-
bit was re Sited for three months and then 
boosted with 0.1 g antigen. It was then 
bled after 10 days, this sample represent· 
ing serum VIII. 
For the purpose of discussion in this 
study, the serum sampl~ obtained from the 
first bleeding will be referred to as early 
rabbit serum. Sera taken from the seventh 
bleeding onwards will be termed ,late rab-
bit sera. 
b) Human immune sera 
Normal pooled human serum and 
paired sera from a patient (E.P.) were in-
vestigated for neutralizing antibodies 
against herpes virus in the presence of 
heated and unheated complement. In the 
latter case, the first blood sample was 
taken at the time of appearance of the 
herpetic lesIons {early antiserum). The 
second blood sample was obtained seven 
weeks after the first and served as the 
late hyperimmune serum. 
c) Mouse immune sera 
Fifteen 3-month old mice were divided 
Immune sera from rabbit No. 466 
HSV type 1 HSV type 2 
_---A.~_, 
---'-
k k k k 
I k+c I k+c l+c 1-c 
Serum +c -c k- c +c -c k -c k k 
No. 2+c 2-c 
I 4.8 1.8 2.6 1.4 0.7 2.0 3.4 2.5 
III 6.1 2.5 2.4 4.2 1.7 2.4 1.4 1.5 
V 8.6 6.3 1.3 5.5 1.7 3.3 1.5 3.7 
VII 8.3 3.8 2.1 7.2 3.9 1.8 1.1 1.0 
VIII 24.1 20.5 1.1 6.8 3.5 1.9 3.5 5.7 
Immune sera from rabbit No. 467 
HSV type 1 HSV type 2 
--
.f>~8Zi'l /----
----
k rk k ik 
I k+c I !k+c l+·c 1-c 
~ ~ 
Serum +c -c k-c +c -c rk~c !k k 
No. 2+c 2-c 
I 6.3 3.8 1.6 1.2 0.3 4.0 5.2 12.6 
III 6.6 3.4 1.9 4.9 l.7 2.8 1.4 2.0 
V 12.6 6.6 1.9 10.8 6.6 1.6 1.1 1.0 
VII 14.7 6.9 2.1 10.8 6.4 l.7 1.3 1.1 
VIII 16.6 10.1 1'.6 6.6 2.8 2.3 2.5 3.4 
Table 1. - The neutralization rate constant (Ik) values of immune sera from rab-
hits Nos. 466 anid 467 with herpes simplex virus {HSV) ty;pes 1 and 2 in the presence 
(+c) and absence (-c) of complement. 
into three groups and each 'immunized 
once with herpes virus type 1, each mouse 
receiving approximately 107 p.tf.u. The 
virus was rendered inactive by treatment 
with 10% formol saline for 1 h at 37°C 
and injected intra peritoneally. An the 
mice in one group were killed and bled on 
the third day following 'immunization. The 
blood was pooled and {he serum separated 
after alHowing to stand for some hours at 
4°C. The other groups of mice were simi-
larly treated but bleeding was made on the 
tenth and twentieth day post-immuniza-
tion. 
Complement 
Unheated guinea pig serum was used 
as complement. It was stored at -70°C 
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until used. As indicated previously, heated 
guinea pig serum at 56°C for 30 min was 
added to those virus-serum samples which 
were to be tested in the absence of com-
plement. Titration of complement was 
peflformed after the method of Yoshino 
and Tanlguchi (1964). Unheated guinea 
pig serum was diluted serially in phosphate 
buffered saline. 0.05 ml of each dHution 
was then mixed with 0.05 mil of a virus 
suspension containing the same amount 
of p.f.u. as that used in the neutralization 
tests. A sensitized haemolytic system 
made up of equal parts of 3,% washed 
sheep red cells and rabbit anti-sheep hae-
molysin conta·ining 2 units was added to 
all tubes ,in 0.1 ml amounts. Appropriate 
controls were also included. After shak-
ing, the tubes were placed in a waterbath 
Plaques produced by Herpes ,simplex virus type 20n BHK (baby 
hamster kidney) cells. 
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::tt 37°C for 30 min. Reading was made 
at the end of this period and the highest 
dilution oif guinea pig serum giving com-
plete haemolysis was taken to represent 
1 haemolytic un'it in 0.05 ml. 
Results 
Neutralization kinetic tests 
with rabbit sera 
Five successive sera (I, nI, v, VII and 
VIII), each from two rabbits (Nos. 466 and 
467), were examined for neutralizing acti-
vity against both heppes simplex virus 
types 1 and 2 in the presence and absence 
of complement. 
Table 1 shows all the data relat.ing to 
these experiments. It wiN be seen that 
the k value of both rabbit sera against 
type 1 virus both in the presence and ab-
0 
r-
... 
0 
....., 
() 
C1:l 
l-
'+- LL 
0 
0 01 
.,.- c -1 
01 
0 > 
..J > 
I-
::J 
Cf) 
sence of complement was significantly 
grea<ter than the corresponding value 
against type 2 virus. This fact can also 
be seen by examining the last two co-
lumns of the Table which relate to the 
ratio of the k value of type 1 to type 2 
virus. This indicates that the sera were 
more specific to the homologous virus. The 
k+c 
-- ratio (Le., the ratio of the k value 'in 
k c 
the presence of complement to that in the 
absence of complement) of both sera, 
against hOoth types of virus, showed no 
significant difference between the early 
and later sera. This indicates that no 
difference existed in complement depen-
dence for neutralization between the early 
and late sem. 
Fig. 1 shows the neutralization kinetic 
curves of early and late sera from rabbit 
30 60 
Ti me (m in) 
Fig. :1: Neutralization kinetic curves of early and lat~ 'Serum samples of 
rabbit no. 466 with herpesvirus type 1. Early s~rum (diluted 1/10): 0 with 
inactivated C and" with unheated C. Late serum (diluted 1/100): D with 
inactivated C' and. with unh~ated C. 
No. 466. Both sera showed a marked 
neutralizing capacity in the absence of 
complement which was only sHghtly 
enhanced when complement was added. 
The same effect was also seen when the 
same sera were tested against type 2 virus 
and a'lso in ,tests with early and late sera 
from rabbit No. 467. Another, perhaps 
important finding, was that both early 
ra:bhit sera showed a relatively high k 
value when tested 'in the absence of com-
plement (the average value against type 
1 virus was 2.8 and against type 2 virus 
was 0.5). 
The early rabbIt sera therefore con-
tained mainly non-CRN antibodies. The 
late rabbit sera obviously contained simil-
arly non-CRN anHbodies since neutraliza-
tion was marked 'in the absence of comple-
ment. In both cases, neutralization was 
only slightly enhanced when complement 
was added. 
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Neutralization kinetic tests 
with human sera 
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Since it is known that a significantly 
high percentage OIf normal adults possess 
anti-herpes antibodies (Burnet and Lush, 
1939; Yoshino et aI., 1962), pooled human 
serum was tested for neutralizing activity 
against herpes virus type 1 both in the 
presence and in the absence of comp1e-
meat. The result is shown in Fig. 2 It will 
be seen that the serum had relatively 
martked neutralizing ac:tivlity even in the 
absence of complemenlt. 
Since poo;led human serum is expec-
ted to contain a random mixture of early 
and late antiherpes antibodies, it was de-
6ded to test paired sera from patients 
known to have had a herpetic infection 
with a view to find out, if any, differences 
for complement requirement in neutraliz;a-
tion belbween acute (early) and conva-
lescent(late) sera. 
60 
Time(min) 
1 20 
Fig. 2: Neutralization kinetic curves of pooled human serum diluted 1/15: 
o with inactivated C' and i. with unheated c. 
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Human immune sera 
Neutralization data with HSV type 2 
k k+c 
/' 
--
mean Serum (type +c mean -c mean k-c 
and dilution) 
E 5/5 0.21 ) 0.04) 5.25) 
I I I 
E 3/5 0.27r 0.34 0.02 ( 0.036 13.50 r 9.50 
I 
0.05J 11.00 J E 1/5 0.55) 
L 5/5 0.56) 0.24) 2.30) 
0.80 ~ I 2.30 ~ 2.24 L 3/5 0.94 0.35 ~ 0.420 
1.47 J 
I 2.20} L 1/5 0.67 ) 
Neutralization data with HSV type 1 
k k+c 
/' 
--Serum (type +c mean mean -c mean k-c 
and dHution) 
E 5/5 0.11 ) 0.012) 9.10) 
E 3/5 0.12 ~ 0.17 0.012 t 0.018 10.00 ~ 9.30 
0.29J 0.030J 
I 
E 1/5 9.00) 
L 5/5 0.45) 0.333) .. 1.40) 
L 3/5 0.60 } 0.67 0.311 ~ 0.390 1.90 } 1.70 
L 1/5 0.98J 0.533J 1.80J 
Table 2. - The neutral,ization rate constant i(1k) values of 'human early i(E) and late 
(L) sera ifrom patient E.P. Wirth iherpesvirus types 1 and 2 in the presence (+c) and aib-
:sence (-c) of 'complement. 
k k 
2+c 2-c 
,For early :serum: --- 2.0 an1d -- 2.0 
k ik 
l+c 1-c 
k Ik 
2+c 2-c 
For 'late serum: 1.4 and -- = 1.2 
k k 
l+c 1-c 
P,aired sera from a patient (E.P.) were 
tested. This patient had both genital and 
oral herpetic lesions and a type 2 virus 
was 'isolated, The results of tests for 
neutralizing antibodies against both virus 
types and the effect of complement on the 
neutralization curves are shown in Figs. 3 
and 4 and in Tahle 2. The k values were 
higher for type 2 than for type I viru", 
both in the presence and absence of com-
plement. This finding confirmed that in-
fection was due to a type 2 herpesvirus. 
The early serum showed only a sright de-
1 00 
75 
(j) 
::J 
'-
> 
01 50 
c 
> 
> 
'-
::J 
Cf) 25 
::::-'2 
'" 
1/5 
93 
crease in virus infectivity in the absence 
of complement. Ne:utralization was great-
ly enhanced on the addition of comple-
ment. In ,contrast, the late serum showed 
a marked neutralizing capacity in the wb-
sence of comp1ement which was only 
slightly enhanced whencomp'lement was 
k+c 
present. The mean value of the --
k-c 
ratio for the early serum was more than 
9.0 while that of the late serum was only 
approximately 2.0. 
3/5 5/5 
Serum Dilutions 
Fig. 3: Neutralization kinetic curves with Herpesvirus type 2 against serum 
from a patient (E.P.) with a herpetic infection. Surviving virus assay,ed 
after 30 min. Early (acute) serum: 0 with inactivated C and 18 with un-
heated c. Late (convalescent) serum: D with inactivated C and • with 
unheated C'. 
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Serum Dilutions 
Fig. 4: Neutralization kinetic curves with Herpesvirus type 1 against serum 
from a patient (E.P.) with a herpetic infection. Surviving virus assay~d 
after 30 min. Early (acute) serum: 0 with inactivated C and i. with un-
heated c. Late (convalescent) serum: 0 with inactivated C and. with 
unheated C'. 
Neutralization kinetic tests 
with mouse sera 
The results w'ith early rabbit ,and hu-
man antiherpes sera differed in that only 
the latter oontained eRN antibodies. The 
finding tha,t the early rabbit ser'a did not 
contain CRN antibodies in contrast to re-
sults obtainEd by several workers (Yoshi-
no and Tan"igll'chi, 1964; Hampar et al., 
1968; Wallis and Melnick, 1971) may be 
due to the different method employed in 
this study in preparing the immunizing 
antigen, the route of administration and 
the time the sample was taken after the 
immunizing dose. 
In an attempt to investigate this point 
further and to time the appearance O'f CRN 
antibodies, if any, mice were immunized 
with one dose of herpes virus antigen and 
successive blood samples collected as 
described earlier. The sera were 'kept at 
-20°C until all s'amples were taken and 
then tested simultaneously for neutral"iz-
ing activity in the presence and absence 
of complement. The results are shown in 
Fig. 5 and in Table 3. Compared to the 
early human serum at the same dilution 
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Days after Immunization 
Fig. 5: Neutralization kinetic curves with mouse sera taken 3, 10 and 20 
days after immunization with one dnse of herpes simplex virus. In each 
case immune serum was diluted 1/5 and surviving virus assayed after 30 
min. 
0-0 neutralization in the presence of heated (inactivflted) Cl. 
a-,. neutralization in the presence of unheated (active) C. 
(Fig. 3), the first mouse serum sample 
taken on the third day after immunization 
showed moderate neutralizing activity in 
the absence of complement whiCh was 
only slightly enJhanced when complement 
was present. The later serum samples 
showed a marked neutralizing capacity in 
the wbsence of complement and enhance-
ment occurred when complement was 
added. 
The effect of varying concentrations of 
complement on the neutralizing acti-
vity of early rabbit and human sera. 
Fig. 6 shows the results obtained in 
this exper,iment. Complement was diluted 
to contain the stated number of units in 
0.05 ml. In other respects, the neutraliza-
tion tests were carried out as described 
earlier. The early human serum showed 
little, if any, neutralizing activity in the 
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absence of complement. Neutralization 
proceeded on the addition of complement 
reaching a maximum at ,the 2.5 unit level 
after which excess of oomplement seemed 
to have no increased enhancing effect. In 
the case of early rabbit serum, neutmliza-
tion was marked in the absence of 'Com-
plement and viral infectivity was reduced 
to approI)C,imately 20%. Neutralization was 
s'lightly enhanced by complement, again 
reaching a maximum in the 2.5-5 unit 
range and then remained constant even in 
the presence of excess complement. 
Discussion 
The experiments described in this 
thesis show that the neutralization of 
herpes simplex virus is enhanced by the 
presence of oomplement. 
In moslt studies cited in the l'iterature, 
dilution end-point neutralization tests were 
carried out to differentiate sera contain-
ing eRN antibodies Ifrom those containing 
non-CRN ones. Ln the present study, only 
kinetic neutralization tests were performed 
and th:s, perhaps, makes it more d.ifficult 
to differentiate these two types of antibo-
dies, especially in ''border-line' cases. 
The early rabbit anfibodiescannot be 
classed as complement-requiring fo,r neu-
tralization of herpes virus since neutral,iza-
tion was marked in Ithe absence of comple-
ment. These results differ from those 
obtained by Yoshino and Taniguchi (1964; 
1965a), Hampar et al. (1968) and Wallis 
and Melnick (1971) who showed that early 
rabibit antiherpes sera conta'ined only eRN 
anti'bodies. This observation may reflect 
differences in the immunization procedures 
employed. Thus, the ,immune sera used 
in neutraIiza,tion experiments by the above 
workers were raised by injecting virus 
intravenously without the addition of ad-
juvant and the early .serum sample col-
lected 7 to 8 days after the immunizing 
dose. The immune Ifabbit sera employed 
in this study were raised by injecting 
freeze-dried antigen 'in Freund" s adjuvant 
intramuscuIarly,and the early 'serum sam-
ple collected 10 days after the first immu-
nizing dose. The method employed in pre-
paring the immunizing antigen, the route 
Mouse immune sera 
Ik 
------~ k+c Serum +c 
-c 
k-c 
3 day 0.29 0.12 2.4 
10 day 1.69 0.57 2.9 
20 day 2.10 0.78 2.6 
Table 3. The neutralization mte 
constant (Ik) values of mouse sera Wli'tlh 
herpesvirus type 1 in the presence (+c) 
and absence (-c) of comp'lement. 
Mice were immunized once with her-
pes v;irus type 1 and serum samples 'Col-
lected on the 3rd, 10th and 20th day after 
immunization. 
All sera 'Ulsed in this eXlpefiiment were 
diill'uifed ':ni'tially 1/5 and surviving virus 
assayed after 30 min of neutralization. 
of administration and the time of coIlec-
tion of the serum samples may thus !be 
determining factors in the type of antibody 
which the patrticular serum may be ex-
pected to contain. 
In the case of human infeotions witih 
herpes simplex virus, the results obtained 
in this study suggest that antibodies pre-
sent early in infection are dependent on 
complement for neutralization (eRN anti-
bodies) while late sera conta,in non-CRN 
antibodies. These results were similar to 
those obtained by Yoshino and Taniguchi 
(1966) who proposed that detection of 
eRN antibodies in a single sample may 
become a new method for the ealf1y dia-
gnosis of herpetic infections. 
The mOll.se immune sera were raised 
by injecting antigen intraper.itoneally and 
the earliest serum coHected' 3 days after 
immunization. The early mouse anfibo-
dies, in the absence of complement, were 
intermediate in neutralizing potency when 
compared, unde,r the same conditions, 
with early human and rabbit antibodies. 
Enhancement of neutJralization :by com-
plement was greater with early human 
than with early mouse serum. Later 
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mo:use sera, taken from the 10th day 
post-immunization onwards, were shown 
to be progressively less complement re-
quiring for neutralization. Yosh:no and 
'faniguchi (1964) detected only eRN anti-
bodies as eady as the 3rd day after the 
immunization of rabbits. The statement 
that the first mouse serum sample simil-
ar~y conta'med only CRN ant'ibodies can-
not be made with certainty. In th:s con-
nection, it is perhaps worthwhile to men-
tion that the virus employed in the im-
munizatio'n of mice was grown in BHK 
cells. The effect of BHK antigens on the 
immunization process ocr- the presence of 
anfi-BHK antibodies in the immune sera 
may have affected the neultralization of 
herpes virus by the mouse immune sera. 
The question of the role of comple-
ment in the neutralization of viruses has 
been raised by many authors in the 
literature. Toussaint and Muschel (1962) 
showed that bacteriophage and antibody 
combined in the absence of complement 
but neUltralization occurred on the addition 
of complement. Yoshino and Taniguchi 
(l965b) postulated two steps in the neu-
tralization of herpes virus, the first step 
being irreversib~e binding between virus 
and antibody (which may still be infec-
tious) and the second step, inactivation 
of virus. In the case of early ,immune 
serum containing only, O!f mainly CRN 
antibodies, the second step may be 
brought about by complement. The action 
of complement in this respect may ,then 
be similar :to other antigen-antibody 
reactions involv:ng comp.lement such as 
ceE lysis by antiserum (Oda and Puck, 
1961). Berry and Alme'ida (1968) showed 
that avian infectious bronchitis virus, ,in 
the presence of antibody and complement, 
developed pits in the envelope which were 
very similar to those present on the mem-
branes of sensitized erythrocytes lysed by 
complement. Th:s suggests that the ac-
tion of complement was to cause viroly-
sis. WaUis and Melnkk (1971) have 
propo'sed that the role of comp'lement in 
virus neutralization was to cause immuno-
aggregates. 
Hamper et al. (1968; 1971) showed 
that 7S and 19S rabbit antibodies to herpes 
simplex virus from early and late sera 
d·iffe:ed in their requirement for comple-
ment for subsequent neutralizafion. The 
early 7S and 19S antibodies showed low 
neutralizing activity in the absence of 
ccmplement and greatly enhanced neut-
ralizing capacity on the addition of com-
plement. In contrast, ibo,th late 7S and 
19S antiibod"ies neutralized virus to a 
marked degree in the absence of comple-
ment although again, neutralization was 
enhanced when complement was added. 
The early rabbit sera used in this 
study seemed to conta'in mainly late 7S 
and 19S antibodies since neutr'alization 
was marked in the absence of comple-
ment. 
The eady human antiherpes sera ap-
peared to contain mainly ear.ly 7S and 19S 
anfibodies as defined Iby Hampar et a/. 
(1968) since neutralization was 'low or 
negEgible in the absenoe of complement 
and greaey enhanced when complement 
was added. These antibody types wer'e 
later replaced by late 7S and 19S anti-
bootles as the late antiserum showed a 
marked neutralizing potency in the ab-
sence of complement. 
The experiments with the mouse im-
mune sera showed the sequentia.l appear-
ance olf antibodies having successively 
less dependence on comp1ement for the 
neutralization of herpes simplex vitrus as 
immunization progressed: 
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SOME MORAL PROBLEMS 
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This p3per is an abridged version of the 
St. Luke's Day lecture delivered to the 
Malta Branch of the British Medical Asso-
chltion on the 18th October 1972 at the 
Medical School of the University. 
When deaHng with the moral aspects 
of transplants one has to bhink of a double 
operation, that by which the tissue or 
org.an is taken from one person, and that 
by wnich it is grafted on to another: hence 
we should consider both the receiver and 
the donor. 
As regards the receiver the doctor 
should be sure that the patient will die if 
the transplant is not made, and that, be-
sides, there is a good probability of the 
operation being successful. The surgeon 
should also have the consent of the pa-
tient, or, if he is a minor, of his parent 
(fabher) or tutor. 
As regards the donor, the transplant 
may be an autograft, or a graft from an-
other person. In the first case there 'is no 
difficulty as aB the parts of a Hving hu-
man org.anism are ordained to the benefit 
of the whole. The surgeon has only to be 
morally sure, medically, that both excision 
and graft are necessary for the patient's 
surviva'l and scientificaByHkely to be suc-
cessful (ef. Fr. Gera1d KeUy, "Notes on 
Moral Theology, 1951", in Theological 
